Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform: Brands Get Damages, Generics Have Inequitable Conduct

Executive Summary

Patent reform legislation exited the Senate Judiciary Committee April 2 without apportionment of damages or inequitable conduct language, providing both brand and generic pharmaceutical companies with something to like
Advertisement

Related Content

Patent Reform Bill In Senate Could Reduce "Inequitable Conduct" Litigation
Patent Reform Bill In Senate Could Reduce "Inequitable Conduct" Litigation
Patent Reform Bill Negotiations Accelerate; Hatch Wants No-Fault Re-Issues
Patent Reform Bill Negotiations Accelerate; Hatch Wants No-Fault Re-Issues
BIO Chairman Sees "Science-Driven" Hamburg As Plus For Regulatory Climate
BIO Chairman Sees "Science-Driven" Hamburg As Plus For Regulatory Climate
Follow-On Biologics “Integrally Related” To Patent Reform Bill, Sen. Hatch Says
Patent Reform Legislation Introduced; Damages, Inequitable Conduct In Flux
Patent Reform Bill In House Limits “Inequitable Conduct” Defense
Patent Reform Bill In House Limits “Inequitable Conduct” Defense

Topics

Advertisement
UsernamePublicRestriction

Register

PS050915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel